Taurine

Taurine is a sulfur-containing amino acid that is not used to build proteins. It sits free in cells, at high concentration in muscle, heart, brain, and retina, where it has roles in bile acid conjugation, osmoregulation, and calcium signaling.

In June 2023, Parminder Singh and colleagues published a paper in Science titled 'Taurine deficiency as a driver of aging.' The study reported that circulating taurine levels decline with age in mice, monkeys, and humans, and that taurine supplementation extended lifespan in mice and improved healthspan markers in middle-aged monkeys [1]. It was treated as a landmark finding, one of the few papers to propose a single measurable molecule as a causal driver of the aging process itself, with a plausible route to a human intervention.

In June 2025, a separate team led by Maria Emilia Fernandez and Rafael de Cabo published a direct rebuttal in the same journal, Science, titled 'Is taurine an aging biomarker?' Analyzing three independent human cohorts alongside animal data, they found taurine levels did not consistently decline with age, and in several cohorts actually increased or stayed flat [2]. This was not a minor caveat attached to a follow-up study. It was a full rebuttal published in the same top-tier venue that carried the original claim, directly contradicting the central premise of the 2023 paper.

A third paper, published in Aging Cell in 2025 by Marcangeli and colleagues, provided independent confirmation of the rebuttal: examining taurine's relationship to age, muscle mass, strength, and mitochondrial function in a separate human cohort, the researchers found no consistent association in any direction [3]. Two independent groups, using different cohorts and methods, both failed to replicate the foundational premise of the original 2023 paper within two years of its publication.

What the evidence does not show, at this point, is that taurine deficiency drives human aging, or that raising taurine levels through supplementation will replicate the lifespan extension seen in the original mouse experiments. The National Institutes of Health issued a public statement in 2025 concluding that taurine is unlikely to be a good biomarker of aging, a notably direct statement for a federal research agency to make about a molecule that had, two years earlier, driven substantial public and commercial interest [4].

The self-experimentation community, including high-profile longevity practitioners, adopted taurine supplementation in 2023 and 2024 on the strength of the original Science paper, before either rebuttal existed. This is n=1 self-report timed to a single positive finding, not evidence that survived the subsequent scientific correction process; anyone who adopted a taurine protocol based on the 2023 paper adopted it before the field had a chance to check the claim.

Critics of the original 2023 paper have noted that human epidemiological data on circulating taurine and aging is inherently noisy, sensitive to diet, kidney function, and time of sample collection, which may explain why three different research groups analyzing different cohorts reached different conclusions about the same basic relationship.

The honest takeaway: taurine went from a proposed master regulator of aging to a molecule whose basic age-correlation could not be reproduced by two independent research teams within two years, and nobody should treat the original 2023 finding as settled science.

2026 RCT: Taurine Reduces Fatigue

A randomized controlled trial published in Hepatology Communications found that L-taurine supplementation reduced fatigue in patients with decompensated cirrhosis [1]. While this is a disease-specific population, it adds to the growing human RCT evidence for taurine. Taurine gained attention in longevity research after a 2023 Science paper showed age-related decline in taurine levels and lifespan extension in mice. A 2026 review in Food and Function examined taurine supplementation at the crossroads of metabolism and aging [2].

Products with this: Taurine